EACR-23 workshop - Free attendance
EACR-23 pre-congress Workshop at Technische Universität München
free attendance

BD Biosciences – NanoString Technologies
Innovative Technologies for Cancer Research Applications

July 4, 2014 - Munich, Germany
Hörsaal D, Technische Universität München, Fakultät für Medizin



BD Biosciences and NanoString Technologies are pleased to invite you to their EACR-23 pre-Congress workshop that aims to provide the latest insights on cell analysis and molecular biology techniques for scientists working in cancer research. This workshop will allow participants to learn and engage in open discussions about how flow cytometric and genomics applications can be applied to advance cancer-related research areas such as apoptosis, cell signaling pathways, proliferation and gene expression profiling.

The program will start with an overview of flow cytometry and gene expression technologies. We will discuss their applications and describe an innovative complete workflow that enables single cell, characterization, isolation and genomic analysis for cancer research studies. The contribution of these technologies to the advancement of cancer research will be illustrated by two invited speakers, who will share their recent results and experience.

We look forward to meeting you in Munich!

BDBD Biosciences-Europe, Erembodegem-Dorp 86, 9320 Erembodegem, Belgium
BD, BD logo and all other trademarks are property of Becton, Dickinson and Company.
© 2014 BD

For Research Use Only. Not for use in diagnostic or therapeutic procedures.

To improve BD products and services and provide you with more relevant information, you accept that we may track and store preference data on products and articles of interest to you when you access additional resources through the links above. To learn about objecting to such collection or your other rights, see the BD Website Privacy Policy.

Unsubscribe | Update your profile | Data Protection | Contact Us (or simply reply)

This email has been sent to: %%EMAIL%% (%%BP NUMBER%%)